Landau Jeffrey B

CIK 00019186151 companySOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001918615

Recent Transactions

20 trades

Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2024-08-20+11,250→ 123,237 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Performance Stock Units (PSUs)
2024-08-20−11,250→ 0 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2024-08-20$1.23/sh−4,181→ 119,056 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2024-03-19$2.09/sh−6,562→ 110,060 total
Award
CytomX Therapeutics, Inc.$CTMX
Common Stock
2024-01-18+30,000→ 116,622 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2024-01-18+140,000→ 140,000 total
Award
CytomX Therapeutics, Inc.$CTMX
Performance Stock Units (PSUs)
2024-01-18+75,000→ 75,000 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2023-12-20$1.38/sh−4,077→ 86,622 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Performance Stock Units (PSUs)
2023-12-17−11,250→ 11,250 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2023-12-17+11,250→ 90,699 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2023-09-22$1.30/sh−4,119→ 76,379 total
Award
CytomX Therapeutics, Inc.$CTMX
Common Stock
2023-09-20+11,250→ 80,498 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2023-03-16$1.98/sh−1,477→ 69,248 total
Award
CytomX Therapeutics, Inc.$CTMX
Common Stock
2023-02-02+40,000→ 70,725 total
Award
CytomX Therapeutics, Inc.$CTMX
Performance Stock Units (PSUs)
2023-02-02+75,000→ 75,000 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2023-02-02+100,000→ 100,000 total
Award
CytomX Therapeutics, Inc.$CTMX
Performance Stock Units (PSUs)
2022-08-10+22,500→ 22,500 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2022-08-10+135,000→ 135,000 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2022-07-20$1.42/sh−4,206→ 30,725 total
Award
CytomX Therapeutics, Inc.$CTMX
Common Stock
2022-07-19+11,250→ 34,931 total

Companies

CytomX Therapeutics, Inc.
Chief Business Officer
$CTMX

Recent Filings

Address

C/O CYTOMX THERAPEUTICS, INC. 151 OYSTER POINT BLVD., STE. 400

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov